Walden Group Healthcare M&A Blog

Colfax Corporation’s DJO Subsidiary Acquires Stryker’s Ankle and Finger Arthroplasty Systems

11/23/2020
Colfax Corporation’s subsidiary DJO, a maker of devices for musculoskeletal health, joint reconstruction, vascular health, and pain management, has acquired Stryker’s STAR® Ankle and Finger Arthroplasty Systems. The STAR® system is used to replace an arthritic ankle joint due to osteoarthritis, post-traumatic arthritis or rheumatoid...
Read More
Teleflex Buys Z-Medica for $500m from Linden Capital

11/9/2020
Teleflex (NYSE: TFX) has purchased hemostatic device developer Z-Medica from healthcare private equity firm Linden Capital. The acquisition adds a portfolio of hemorrhage control dressings comprised of gauze impregnated with kaolin, a clay mineral. Z-Medica’s products address the trauma surgery, EMS, military, emergency department, and...
Read More
Katena Products Acquires Micro-Select Instruments, Inc.

10/26/2020
Katena Products, producer of ophthalmic instruments, biologics, and lenses and portfolio company of private equity firm Audax Group, is buying St. Clair, MO-based Micro-Select Instruments, a manufacturer of ophthalmic forceps, needle holders, speculums and other instruments. The acquisition builds on Katena’s November 2019 purchase of St....
Read More
Steris plc Acquires Key Surgical for $850m

10/12/2020
Ireland-based Steris plc, a $3.1b provider of specialty sterilization solutions, equipment processing and endoscope repair services has acquired Key Surgical, a producer of consumables used in minimally-invasive procedures, from private equity firm Water Street. The acquisition adds OR-focused instruments and other sterile, single-use products...
Read More
QIAGEN Acquires NeuMoDx Molecular for $248m

9/29/2020
Netherlands-based QIAGEN N.V. (NYSE: QGEN), a $1.5b developer of molecular diagnostic equipment and assays, has acquired a 80.1% ownership stake in diagnostics instruments maker NeuMoDx Molecular, Inc. for $248m. Qiagen had purchased a 19.9% ownership stake in NeuMoDx in 2018. The acquisition builds on QIAGEN’s portfolio of automated...
Read More